View : 391 Download: 0
Toll-Like Receptor 7 (TLR7) Mediated Transcriptomic Changes on Human Mast Cells
- Title
- Toll-Like Receptor 7 (TLR7) Mediated Transcriptomic Changes on Human Mast Cells
- Authors
- Cho, Kyung-Ah; Choi, Da-Won; Park, Minhwa; Kim, Yu-Hee; Woo, So-Youn
- Ewha Authors
- 우소연; 조경아; 김유희
- SCOPUS Author ID
- 우소연; 조경아; 김유희
- Issue Date
- 2021
- Journal Title
- ANNALS OF DERMATOLOGY
- ISSN
- 1013-9087
2005-3894
- Citation
- ANNALS OF DERMATOLOGY vol. 33, no. 5, pp. 402 - 408
- Keywords
- Mast cell; Skin inflammation; Toll-like receptor 7
- Publisher
- KOREAN DERMATOLOGICAL ASSOC
- Indexed
- SCIE; SCOPUS; KCI
- Document Type
- Article
- Abstract
- Background: Mast cells are skin immune sentinels located in the upper dermis, where wheal formation and sensory nerve stimulation take place. Skin inflammation is occasionally accompanied by mast cell-driven responses with wheals, angioedema, or both. Immunoglobulin E (IgE) antibodies are regarded as typical stimuli to drive mast cell activation. However, various causative factors, including microbial infections, can drive IgE-independent mast cell response. When infected, the innate immunity orchestrates an immune response by activating receptor signaling via Toll-like receptors (TLRs). Objective: In this study, we determined the effect of TLR7 stimulation on mast cells to investigate the possible mechanism of IgE-independent inflammatory response. Methods: Human mast cell (HMC) line, HMC-1 cells were treated with TLR7 agonist and the morphologic alteration was observed in transmission electron microscopy. Further, TLR7 agonist treated HMC-1 cells were conducted to RNA sequencing to compare transcriptomic features. Results: HMC-1 cells treated with TLR7 agonist reveals increase of intracellular vesicles, lipid droplets, and ribosomes. Also, genes involved in pro-inflammatory responses such as angiogenesis are highly expressed, and Il12rb2 was the most highly up regulated gene. Conclusion: Our data suggest that TLR7 signaling on mast cells might be a potential therapeutic target for mast cell-driven, IgE-independent skin inflammation. (Ann Dermatol 33(5) 402 similar to 408, 2021)
- DOI
- 10.5021/ad.2021.33.5.402
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML